SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-159996
Filing Date
2024-06-12
Accepted
2024-06-12 16:42:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d837544ddefa14a.htm DEFA14A 37595
  Complete submission text file 0001193125-24-159996.txt   38659
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40708 | Film No.: 241038945
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)